You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Related products

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

Anti-cIAP2 antibody (ab2540)

CodeSizePriceAbpointsAvailability
    
 
  • -
  •   
  •   
  •   
  •  
  •   
  •   
Updating...

Overview

Product name

Anti-cIAP2 antibody
See all cIAP2 products (6) ...

Description

Rabbit polyclonal to cIAP2

Tested applications

WBmore details

Cross reactivity

Reacts with

Human

Does not react with

Mouse

Immunogen

Available on request. (Peptide available as ab38273.)

Properties

Form

Liquid

Storage instructions

Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.

Storage buffer

Preservative: 0.01% Thimerosal (merthiolate)
Constituents: 30% Glycerol, 0.5% BSA, PBS, pH 7.2

Concentration

Concentration information loading...

Purity

Immunogen affinity purified

Clonality

Polyclonal

Isotype

IgG

Applications

Show applications key

Our Abpromise guarantee covers the use of ab2540 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application notes

WB: Use at a concentration of 1 - 3 µg/ml.

In Western blot, this antibody detects a band of approximately 68 kDa.

Not tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.

Target

Function

Apoptotic suppressor. The BIR motifs region interacts with TNF receptor associated factors 1 and 2 (TRAF1 and TRAF2) to form an heteromeric complex, which is then recruited to the tumor necrosis factor receptor 2 (TNFR2).

Tissue specificity

Highly expressed in fetal lung, and kidney. In the adult, expression is mainly seen in lymphoid tissues, including spleen, thymus and peripheral blood lymphocytes.

Involvement in disease

Note=A chromosomal aberration involving BIRC3 is recurrent in low-grade mucosa-associated lymphoid tissue (MALT lymphoma). Translocation t(11;18)(q21;q21) with MALT1. This translocation is found in approximately 50% of cytogenetically abnormal low-grade MALT lymphoma.

Sequence similarities

Belongs to the IAP family.
Contains 3 BIR repeats.
Contains 1 CARD domain.
Contains 1 RING-type zinc finger.

Cellular localization

Cytoplasm.

Target information above from: UniProt accessionQ13489 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • CIAP 2 antibody
  • Inhibitor of apoptosis protein 1 antibody
  • AIP 1 antibody
  • AIP1 antibody
  • API 2 antibody
  • API2 antibody
  • Apoptosis inhibitor 2 antibody
  • Baculoviral IAP repeat containing 3 antibody
  • Baculoviral IAP repeat containing protein 3 antibody
  • Baculoviral IAP repeat-containing protein 3 antibody
  • BIRC 3 antibody
  • BIRC3 antibody
  • BIRC3_HUMAN antibody
  • C IAP2 antibody
  • C-IAP2 antibody
  • CIAP 2 antibody
  • CIAP2 antibody
  • HAIP 1 antibody
  • HAIP1 antibody
  • HIAP 1 antibody
  • HIAP-1 antibody
  • HIAP1 antibody
  • IAP homolog C antibody
  • IAP-1 antibody
  • Inhibitor of apoptosis protein 1 antibody
  • MALT 2 antibody
  • MALT2 antibody
  • Mammalian IAP homolog C antibody
  • MIHC antibody
  • RING finger protein 49 antibody
  • RNF49 antibody
  • TNFR2 TRAF signaling complex protein 1 antibody
  • TNFR2 TRAF signalling complex protein antibody
  • TNFR2-TRAF-signaling complex protein 1 antibody
see all

References for Anti-cIAP2 antibody (ab2540)

This product has been referenced in:

  • Lopergolo Aet al. Apollon gene silencing induces apoptosis in breast cancer cells through p53 stabilisation and caspase-3 activation. Br J Cancer 100:739-46 (2009). WB; Mouse.Read more (PubMed: 19223905) »
  • Esposito Iet al. Overexpression of cellular inhibitor of apoptosis protein 2 is an early event in the progression of pancreatic cancer. J Clin Pathol 60:885-95 (2007).Read more (PubMed: 16775116) »

See all 4 publications for this product

Publishing research using ab2540? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"